Saturday, July 11, 2026

Drug profile · INN

adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine

adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine (QUATTROVAC) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine
Class
Route
Patents
0
Programs
1
Data quality
0.78

Quick answer

adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine (QUATTROVAC) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine
Brand QUATTROVAC

Approval history

Authority Status Date
PMDA approved

Pipeline programs

  1. Sabin Strain Inactivated Poliovirus Vaccine Phase 3 · Sinovac Research and · Poliomyelitis

Frequently asked questions

What is adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine?

adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine (QUATTROVAC) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine?

QUATTROVAC is a marketed brand name for adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (sabin strain) combined vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.